7-氨基异喹啉-5,8-二酮 | 118680-81-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 中文名称: 7-氨基异喹啉-5,8-二酮
• 英文名称: 7-aminoisoquinoline-5,8-dione
• CAS: 118680-81-2
• 化学式: C₉H₆N₂O₂
• 分子量: 174.159
• InChiKey: YVQCXUHOMPHZNA-UHFFFAOYSA-N

物化性质

• 熔点：
  287 °C
• 沸点：
  364.0±42.0 °C(Predicted)
• 密度：
  1.435±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  73
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  7-氨基异喹啉-5,8-二酮 在 四丁基氟化铵 、 sodium hydride 、 三乙胺 作用下， 生成 2-[3-[2-(Dimethylamino)ethyl]-4,9-dioxopyrrolo[3,2-g]isoquinolin-1-yl]ethyl methanesulfonate
  参考文献：
  名称：

  Synthesis and antiproliferative activity of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives: Part II

  摘要：

  A series of 6-azanaphthoquinone pyrrolo-annelated derivatives carrying different basic side chains have been synthesized. The antiproliferative activities of all compounds were evaluated on at least four different cell lines with Mitoxantrone as reference compound. Cytotoxic effects and DNA intercalation behavior were investigated. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.03.013
• 作为产物：
  描述：

  5-硝基异喹啉 在 盐酸 、 硫酸 、 氨 、 溴 、 硝酸 、 tin(ll) chloride 作用下， 以 甲醇 、 二氯甲烷 、 水 为溶剂， 反应 3.58h， 生成 7-氨基异喹啉-5,8-二酮
  参考文献：
  名称：

  Abdelwahab, Ahmed B.; Shaaban, Mohamed; Ismail, Mohamed A.H., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2014, vol. 53, # 8, p. 1098 - 1109

  摘要：

  DOI：

文献信息

• Synthesis of 5,6-, 5,8- and 7,8-Isoquinolinediones from the Corresponding Isoquinolinols and Dimethoxyisoquinolines.
  作者：Yoshiyasu KITAHARA、Tatsuya NAKAI、Shinsuke NAKAHARA、Manabu AKAZAWA、Masaro SHIMIZU、Akinori KUBO

  DOI：10.1248/cpb.39.2256

  日期：——

  5, 8-Isopuinolinediones (12, 18, 25), 7, 8-isoquinolinediones (14, 19) and 5, 6-isoquinolinediones (26) were synthesized by oxidative demethylation of the corresponding dimethoxyisoquinolines with cerium(IV) ammonium nitrate or silver(II) oxide. 8-Dialkylamino-5, 6-isoquinolinediones (31) and 3, 5-bis(dialkylamino)-7, 8-isoquinolinediones (33) were prepared by copper(II)-catalyzed oxidation of the corresponding isoquinolinols with secondary amines. 5, 8-Isoquinolinediones (29, 34, 40) were also prepared.

  5, 8-异喹啉二酮（12, 18, 25）、7, 8-异喹啉二酮（14, 19）和5, 6-异喹啉二酮（26）是通过与铈（IV）铵硝酸盐或银（II）氧化物的氧化脱甲基反应合成的。8-二烷基氨基-5, 6-异喹啉二酮（31）和3, 5-双（双烷基氨基）-7, 8-异喹啉二酮（33）是通过铜（II）催化的相应异喹啉醇与二级胺的氧化反应制备的。5, 8-异喹啉二酮（29, 34, 40）也已被制备。
• 1,2 나프토퀴논 유도체 및 이의 제조방법
  申请人：YUNGJIN PHARM. CO., LTD. 영진약품 주식회사(119980028225) Corp. No ▼ 110111-0043127BRN ▼218-81-00352

  公开号：KR20150080425A

  公开（公告）日：2015-07-09

  본 발명은 하기 화학식 (1)로 표시되는 화합물, 그것의 약제학적으로 허용되는 염, 수화물, 용매화물, 프로드럭, 토토머(tautomer), 거울상 이성질체 또는 약학적으로 허용 가능한 부분입체 이성질체와, 이의 제조 방법 및 이를 함유하는 대사성 질환 치료 또는 예방 효과를 가지는 의약 조성물에 관한 것이다. (1)상기 화학식 1에서, R내지 R, 및 X 내지 X은 제1항에서 정의된 바와 같다.

  本发明涉及一种化合物，其用以下化学式（1）表示，以及该化合物的药学上可接受的盐、水合物、溶剂化合物、前体、互变异构体、镜像异构体或药学上可接受的部分立体异构体，以及其制备方法和含有该化合物的治疗或预防代谢性疾病的药物组合物的效果。在上述化学式1中，R至R和X至X如第1款所定义。
• 1,2-NAPHTHOQUINONE DERIVATIVE AND METHOD FOR PREPARING SAME
  申请人：KT&G Life Sciences Corporation

  公开号：EP3091005A1

  公开（公告）日：2016-11-09

  Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R3,and X1 to X6 are the same as defined in Claim 1.

  本发明公开了由式（1）代表的化合物或其药学上可接受的盐、水合物、溶液剂、原药、同系物、对映体或药学上可接受的非对映异构体、制备方法和药物组合物，其具有治疗或预防代谢综合征的效果： 其中 R1 至 R3 和 X1 至 X6 与权利要求 1 中定义的相同。
• 1,2-naphthoquinone based derivative and method of preparing the same
  申请人：HUEN Co., Ltd.

  公开号：US10927085B2

  公开（公告）日：2021-02-23

  Disclosed are a compound represented by Formula (1) below, or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R3,and Xi to X6 are the same as defined in claim 1.

  本发明公开了由下式（1）代表的化合物或其药学上可接受的盐、水合物、溶液剂、原药、同系物、对映体或药学上可接受的非对映异构体、制备方法以及药物组合物，其具有治疗或预防代谢综合征的功效： 其中 R1 至 R3 和 Xi 至 X6 与权利要求 1 中定义的相同。
• Synthesis and biological evaluation of novel cytotoxic azanaphthoquinone annelated pyrrolo oximes
  作者：Karem Shanab、Nipawan Pongprom、Eva Wulz、Wolfgang Holzer、Helmut Spreitzer、Peter Schmidt、Babette Aicher、Gilbert Müller、Eckhard Günther

  DOI：10.1016/j.bmcl.2007.09.054

  日期：2007.11

  Two series of azanaphthoquinone annelated pyrrolo oximes have been synthesized. The antiproliferative activities of 10 compounds were evaluated on at least four different cell lines. One series of pyrrolo derivatives showed high cytotoxic activity. The effects on cell cycle and caspase activity were investigated. Compounds 9a and 9b showed an accumulation of cells in G2/M phase. Substantial and dose-dependent caspase activity was found after treatment of cells with 9a and 9b. This indicates an apoptosis inducing property of these compounds. (C) 2007 Published by Elsevier Ltd.